This product was withdrawn from the Community Register of designated orphan medicinal products in July 2008 on request of the sponsor.
On 5 March 2001, orphan designation (EU/3/01/027) was granted by the European Commission to Orphan Europe, France, for ibuprofen for the prevention of patent ductus arteriosus in premature neonates of less than 34 weeks of gestational age.
Patent ductus arteriosus in premature neonates of less than 34 weeks of gestational age
|Orphan designation status||
|EU designation number||
|Date of designation||
Documents related to this orphan designation evaluation
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
EU register of orphan medicines
The list of medicines that have received an orphan designation in the EU is available on the European Commission's website: